Avenue Therapeutics (ATXI US)

Avenue Therapeutics, Inc. operates as a specialty pharmaceutical company. The Company focuses on the development and commercialization of products principally for use in the acute and hospital setting. Avenue Therapeutics develops an intravenous formulation of tramadol HCI for the treatment of moderate to moderately severe post-operative pain.